Register now for the 2022 Big Ten CRC Summit held Saturday, November 19, 2022, in Columbus, Ohio.
We invite all senior/junior faculty and fellows involved in clinical oncology research, basic scientists involved in drug discovery and translational research, cancer center leadership and administration, community leaders and patient advocates to join us in Columbus at no cost for registration. Industry leaders and medical science liaisons are invited to the summit and to give pipeline presentations for a fee. Read More
September 13, 2022: The University of Nebraska Medical Center, along with its partner Nebraska Medicine, will have additional resources to aggressively pursue the development and testing of new therapies for pancreatic cancer following state support that was approved earlier this year. The state funding for the Big Ten Cancer Research Consortium member included support for the UNMC Pancreatic Cancer Center of Excellence, led by Sunil Hingorani, MD, PhD, a highly accomplished and internationally recognized pancreatic cancer researcher and clinician. Dr. Hingorani joined UNMC in May, calling it a “a unique time in pancreas cancer research and clinical care.” The field has developed a much deeper understanding of the many ways in which the disease evades detection and diagnosis, Dr. Hingorani said. "The timing could not be... Read More
August 15, 2022: The Big Ten Cancer Research Consortium (Big Ten CRC) and Cal’s Angels are pleased to announce a new collaboration to fund Adolescent/Young Adult (AYA) therapeutic cancer clinical trials conducted within the Big Ten CRC. Read More
July 13, 2022: The Big Ten Cancer Research Consortium recently established the Kenneth and Verna Mae Jessen Award after a generous donation of $100,000 from the Verna Mae Jessen Trust. The trust supports nonprofit organizations working in cancer or pain management research. The Kenneth and Verna Mae Jessen Award will provide funding for basic, correlative, clinical, or population science oncology research. Read More
July 8, 2022: This month, the Big Ten Cancer Research Consortium (Big Ten CRC) highlights University of Illinois Cancer Center (UIC) as our featured member. UIC members Kent Hoskins, MD, Oana Danciu, MD and Yu "Tom" Gao, PhD, have been collaborating on BTCRC-BRE15-016, a trial identifying exosome protein biomarkers in patients with advanced hormone receptor-positive breast cancer treated with palbociclib and tamoxifen. Read More
April 20, 2022: This month, the Big Ten Cancer Research Consortium (Big Ten CRC) highlights The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J, Solove Research Institute (OSUCCC) as our featured member. OSUCCC - James member Dwight Owen, MD, MSc is a medical oncologist and member of the Translational Therapeutics Program at the OSUCCC- James. Dr. Owen is a member of the Big Ten CRC’s correlative sciences clinical trial working group and a co-chair of the thoracic clinical trial working group. Dr. Owen shares why he is glad to be part of the Big Ten Cancer Research Consortium. Read More
April 13, 2022: When I was recruited to Ohio State in 2009 as director of the Department of Radiation Oncology, one of our long-term goals was to extend our therapeutic reach by establishing central Ohio’s first proton therapy center in partnership with nearby Nationwide Children’s Hospital. The center would enable both adult and pediatric patients to receive the very latest radiotherapy – namely proton therapy – in one facility that is closer to their homes, making it a less disruptive life experience. Proton therapy uses protons, or positively charged particles found within atoms, instead of X-rays to kill cancer cells. Because it... Read More
March 10, 2022: This month, the Big Ten Cancer Research Consortium (Big Ten CRC) highlights the University of Michigan Rogel Cancer Center as our featured member. Rogel Cancer Center member Ryan Wilcox, MD, PhD, is an associate professor of hematology/oncology at Rogel and a member of the Big Ten CRC’s lymphoid malignancies clinical trial working group. He has participated in two Big Ten CRC trials. Dr. Wilcox shares why he’s glad to be part of the Big Ten Cancer Research Consortium. Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube